# Hologic awarded $119M U.S. government contract to double COVID-19 test production

Hologic received a $119 million contract from HHS and the Department of Defense to scale up COVID-19 test manufacturing capacity. The funding will enable Hologic to produce 13 million COVID-19 tests per month in the U.S. by January 2022, up from 6 million globally as of July 2020.

- Type: Contract
- Announced: 2020-11-02
- Where: California, Maine, Wisconsin, United States
- Value: $119.0M
- Status: announced
- Capacity: 13 million COVID-19 tests per month
- Products: COVID-19 tests, Panther and Panther Fusion systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Hologic](https://endata.com/companies/22178.md)
- [U.S. Department of Defense](https://endata.com/companies/4836.md) (customer)
- [U.S. Department of Health and Human Services](https://endata.com/companies/46441.md) (customer)

## Sources

- [medtechdive.com](https://www.medtechdive.com/news/hologic-coronavirus-test-production-hhs-dod-contract/588186/), 2020-11-02: "We believe this expansion at least doubles [Hologic's] current COVID-19 test capacity in the US, and should enable the company to produce >55MM total molecular tests/quarter vs. the previously disclosed capacity of ~40MM/quarter."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/uncategorized/54293/), 2020-11-02: "Hologic has been awarded a $119 million US government contract for the expansion of its production capacity for Covid-19 molecular tests."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.